Factors Associated with Local Recurrence After Neoadjuvant Chemoradiation with Total Mesorectal Excision for Rectal Cancer

Nam-Kyu Kim; Young-Wan Kim; Byung-Soh Min; Kang-Young Lee; Seung-Kook Sohn; Chang-Hwan Cho
August 2009
World Journal of Surgery;Aug2009, Vol. 33 Issue 8, p1741
Academic Journal
The purpose of the present study was to investigate risk factors associated with local recurrence in patients with locally advanced rectal cancer who received preoperative chemoradiotherapy in combination with total mesorectal excision (TME). Rectal cancer patients who were treated with neoadjuvant chemoradiation with TME were studied. We compared 26 patients who developed local recurrence with 119 recurrence-free patients during the follow-up period. The median follow-up period was 52 months (range: 14–131 months). Based on the use of univariate and multivariate analyses, circumferential margin involvement ( p = 0.02), the presence of lymphovascular or perineural invasion ( p = 0.02), and positive nodal disease ( p = 0.03) were contributing factors for local recurrence. The local recurrence rate was different between ypN(+) patients and ypN(–) patients with more than 12 nodes retrieved ( p = 0.01). There was no difference in local recurrence rates between ypN(+) patients and ypN(–) patients with <12 nodes ( p = 0.35) or between ypN(–) patients with <12 nodes or ≥12 nodes ( p = 0.18). Patients with circumferential margin involvement, the presence of lymphovascular or perineural invasion, and positive nodal disease should be regarded as a high-risk group. We also determined that lymph node retrieval (<12 nodes) in patients with node-negative disease was a risk factor for local recurrence.


Related Articles

  • Integration of Novel Agents into Combined-Modality Treatment for Rectal Cancer Patients. Rolf Sauer // Strahlentherapie und Onkologie;May2007, Vol. 183 Issue 5, p227 

    Background:  With optimized local treatment – achieved through preoperative radiochemotherapy (RCT) and total mesorectal excision (TME) surgery – distant metastases are by far the predominate sites of tumor failure in rectal cancer today. The challenge is to integrate more...

  • Preoperative chemoradiation for rectal cancer: kudos and a caution. Kendal, Wayne S.; Stern, Hartley S. // Canadian Journal of Surgery;Apr2004, Vol. 47 Issue 2, p87 

    Analyzes the role of preoperative chemoradiation in the management of rectal cancer. Benefits of surgical management of patients with rectal cancer; Issue of potential salvage rate for recurrent cancer after an initial clinical complete response; Dose of multiple daily fractions for a period of...

  • Distal clearance margin of 1 cm or less: a safe distance in lower rectum cancer surgery. Leo, Ermanno; Belli, Filiberto; Miceli, Rosalba; Mariani, Luigi; Gallino, GianFrancesco; Battaglia, Luigi; Vannelli, Alberto; Andreola, Salvatore // International Journal of Colorectal Disease;Mar2009, Vol. 24 Issue 3, p317 

    The purpose of this study was to investigate the prognostic role of distal clearance margin (DCM) in lower rectum cancer surgery. Two-hundred-three cancer patients underwent total rectal resection, possibly followed by adjuvant chemoradiotherapy. DCM was classified as positive or negative (<1,...

  • Locally Advanced Rectal Cancer: What Is the Evidence for Induction Chemoradiation? Glynne-Jones, Rob; Harrison, Mark // Oncologist;Nov2007, Vol. 12 Issue 11, p1309 

    The concept of spatial cooperation in neoadjuvant chemoradiation (CRT) for locally advanced rectal cancer is attractive. Chemotherapy may, as a component of CRT, not only act as a radiosensitizing agent but also potentially eradicate distant micrometastases. Recent trials have demonstrated that...

  • Neoadjuvant Radiochemotherapy for Patients With Locally Advanced Rectal Cancer Leads to Impairment of the Anal Sphincter Theisen, Joerg; Kauer, Werner K.-H.; Nekarda, Hjalmar; Schmid, Ludwig; Stein, Hubert J.; Siewert, Joerg-Ruediger // Journal of Gastrointestinal Surgery;Feb2006, Vol. 10 Issue 2, p309 

    Neoadjuvant radiochemotherapy (RCTx) has become an acceptable therapy for patients with locally advanced rectal cancer. However, little is known about the effect of the RCTx on the function of the anal sphincter. Forty-one consecutive patients with locally advanced rectal cancer (cT3, N+)...

  • The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer: a practice guideline. Figueredo, Alvaro; Zuraw, Lisa; Wong, Rebecca K. S.; Agboola, Olusegun; Rumble, R. Bryan; Tandan, Ved // BMC Medicine;2003, Vol. 1, p1 

    Background: This systematic review with meta-analysis was designed to evaluate the literature and to develop recommendations regarding the use of preoperative radiotherapy in the management of patients with resectable rectal cancer. Methods: The MEDLINE, CANCERLIT and Cochrane Library databases,...

  • Transanal endoscopic vs total mesorectal laparoscopic resections of T2-N0 low rectal cancers after neoadjuvant treatment. Lezoche, E.; Guerrieri, M.; Paganini, A. M.; D'Ambrosio, G.; Baldarelli, M.; Lezoche, G.; Feliciotti, F.; De Sanctis, A. // Surgical Endoscopy;Jun2005, Vol. 19 Issue 6, p751 

    Background: This study aimed to compare the results and the oncologic outcomes of transanal endoscopic microsurgery (TEM) with neoadjuvant radiochemotherapy and laparoscopic resection (LR), also with neoadjuvant radiochemotherapy, in the treatment of T2-N0 low rectal cancer. Methods: The study...

  • Neoadjuvant chemoradiotherapy, sepsis and neutrophil levels following radical excision of rectal cancer. Bhangu, Aneel; Nightingale, Peter; Daniels, Darren; Tiramula, Raju // International Journal of Colorectal Disease;Jun2010, Vol. 25 Issue 6, p723 

    This study aimed to determine differences in neutrophil levels between those receiving long-course neoadjuvant chemoradiotherapy (nCXRT) and those proceeding straight to surgery (StS) for rectal cancer, and in those who developed serious septic events within 30 post-operative days within each...

  • Impact of Neoadjuvant Therapy on Postoperative Complications in Patients Undergoing Resection for Rectal Adenocarcinoma. Turner, Immanuel I.; Russell, Gregory B.; Blackstock, A. William; Levine, Edward A. // American Surgeon;Dec2004, Vol. 70 Issue 12, p1045 

    Surgical resection continues to be the mainstay of treatment for rectal cancer. Neoadjuvant therapy (chemotherapy and radiation) has also been shown to be efficacious. The impact of preoperative chemotherapy and radiation on postoperative complications is unclear. The purpose of this study is to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics